Peregrine drug shows promise against breast cancer
by on Jun.02, 2010, under Health and Fitness
A small, mid-stage trial of an experimental breast cancer drug developed by Peregrine Pharmaceuticals Inc showed that 74 percent of patients responded to the treatment, according to the company.
View full post on Yahoo! Health News
